These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11999265)

  • 1. Safety of hormone replacement therapy after mastectomy.
    Del Mar CB; Glasziou PP; Spinks AB; Sanders SL; Hilton DJ
    Med J Aust; 2002 Mar; 176(6):285. PubMed ID: 11999265
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of estrogen plus progestin hormone therapy on breast cancer mortality: still unresolved.
    Schairer C; Brinton LA
    J Natl Cancer Inst; 2013 Apr; 105(8):513-4. PubMed ID: 23543780
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Estrogen plus progestin and breast cancer incidence and mortality in the women's health initiative observational study.
    Shapiro S; deVilliers TJ; Pines A; Sturdee DW; Archer DF; Baber RJ; Panay N; Farmer RD; Stevenson JC; Mueck AO; Burger HG; Gompel A
    J Natl Cancer Inst; 2014 Feb; 106(2):djt372. PubMed ID: 24363446
    [No Abstract]   [Full Text] [Related]  

  • 4. [Estrogen substitution after breast carcinoma?].
    Braendle W
    Internist (Berl); 2001 Jul; 42(7):1039. PubMed ID: 11476047
    [No Abstract]   [Full Text] [Related]  

  • 5. Should women who have had breast cancer take hormone replacement therapy?
    Eden J
    Maturitas; 1995 Sep; 22(2):69-70. PubMed ID: 8538486
    [No Abstract]   [Full Text] [Related]  

  • 6. Hormone replacement and breast cancer: implications of the Iowa Women's Health Study.
    Mayer ME
    Cleve Clin J Med; 1999; 66(10):608-10, 613. PubMed ID: 10598365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re: Breast cancer risk in relation to the interval between menopause and starting hormone therapy.
    Grant EC
    J Natl Cancer Inst; 2011 Jul; 103(13):1069; reply 1069-70. PubMed ID: 21700925
    [No Abstract]   [Full Text] [Related]  

  • 8. Estrogen replacement therapy after localized breast cancer: clinical outcome of 319 women followed prospectively.
    Vassilopoulou-Sellin R; Asmar L; Hortobagyi GN; Klein MJ; McNeese M; Singletary SE; Theriault RL
    J Clin Oncol; 1999 May; 17(5):1482-7. PubMed ID: 10334534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hormone replacement therapy in patients after breast cancer].
    Köninger A; Kümmel S; Kimmig R
    MMW Fortschr Med; 2008 Oct; 150(43):32-4. PubMed ID: 19025144
    [No Abstract]   [Full Text] [Related]  

  • 10. Hormone replacement therapy for breast cancer survivors: an answered question?
    Zielinski SL
    J Natl Cancer Inst; 2005 Jul; 97(13):955. PubMed ID: 15998945
    [No Abstract]   [Full Text] [Related]  

  • 11. Estrogen replacement therapy for the breast cancer survivor: a reappraisal.
    Disaia PJ
    J Surg Oncol; 1997 Mar; 64(3):175-80. PubMed ID: 9121146
    [No Abstract]   [Full Text] [Related]  

  • 12. Hormone replacement therapy and breast cancer morbidity, mortality and recurrence.
    Kenemans P; Scheele F; Burger CW
    Eur J Obstet Gynecol Reprod Biol; 1997 Feb; 71(2):199-203. PubMed ID: 9138966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmenopausal estrogen replacement therapy in the patient with breast carcinoma.
    Cyr MG
    R I Med; 1995 Sep; 78(9):261-3. PubMed ID: 7579723
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ductal carcinoma in situ of the breast].
    Rueda Domínguez A; Alonso Muñoz MC; Gómez Gómez A; Ojeda González B
    Med Clin (Barc); 1993 Oct; 101(14):548-56. PubMed ID: 8231402
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased risk of recurrence after hormone replacement therapy in breast cancer survivors.
    Holmberg L; Iversen OE; Rudenstam CM; Hammar M; Kumpulainen E; Jaskiewicz J; Jassem J; Dobaczewska D; Fjosne HE; Peralta O; Arriagada R; Holmqvist M; Maenpaa J;
    J Natl Cancer Inst; 2008 Apr; 100(7):475-82. PubMed ID: 18364505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ductal carcinoma in situ of the breast: one reason for considering radiotherapy as part of breast-conservation therapy.
    Fentiman IS
    Womens Health (Lond); 2008 Nov; 4(6):579-81. PubMed ID: 19072460
    [No Abstract]   [Full Text] [Related]  

  • 17. Predictors of breast recurrence after conservative surgery and radiation therapy for invasive breast cancer.
    Connolly JL; Boyages J; Nixon AJ; Peiró G; Gage I; Silver B; Recht A; Harris JR; Schnitt SJ
    Mod Pathol; 1998 Feb; 11(2):134-9. PubMed ID: 9504684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radiotherapy in ductal in-situ breast carcinoma effective].
    Sauer R
    Strahlenther Onkol; 1993 Oct; 169(10):624-5. PubMed ID: 8235989
    [No Abstract]   [Full Text] [Related]  

  • 19. Unopposed estrogen therapy and the risk of invasive breast cancer.
    Chen WY; Manson JE; Hankinson SE; Rosner B; Holmes MD; Willett WC; Colditz GA
    Arch Intern Med; 2006 May; 166(9):1027-32. PubMed ID: 16682578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of hormone replacement therapy after mastectomy.
    Hitchins RN
    Med J Aust; 2002 Jun; 176(12):617; author reply 618-20. PubMed ID: 12064965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.